Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab | NEJM
Coronavirus disease 2019 (Covid-19) disproportionately results in hospitalization or death in older patients and those with underlying conditions. Sotrovimab is a pan-sarbecovirus monoclonal antibo...
nejm.org